NVDA Q3 Earnings Alert: Why our AI stock picker is still holding Nvidia stockRead More

Walmart, Super Micro Computer, BioNTech rise premarket; Lowe's falls

Published 2024-11-19, 08:02 a/m
© Reuters
GOOGL
-
MDT
-
WMT
-
LOW
-
SMCI
-
AMCR
-
BNTX
-

Investing.com -- US stock futures fell Tuesday, weighed by heightened geopolitical tensions after Russian President Vladimir Putin issued a thinly-veiled nuclear threat to the US.

Here are some of the biggest premarket US stock movers today:

  • Walmart (NYSE:WMT) stock rose 3.8% after the retail giant reported better-than-expected results for the third quarter, and hiked its annual earnings outlook.

  • Lowe’s (NYSE:LOW) stock fell 1.4% after the home improvement retailer reported a drop in annual comparable sales, reflecting continued softness in DIY bigger-ticket discretionary demand.

  • Alphabet (NASDAQ:GOOGL) stock fell 0.7% after Bloomberg reported the Department of Justice could recommend the tech giant sell off its Chrome browser as part of an antitrust crackdown.

  • Super Micro Computer (NASDAQ:SMCI) stock soared over 26% after the troubled server maker said it had appointed a new auditor and was on track to file its financial reports for the year.

  • Medtronic (NYSE:MDT) stock rose 0.2% after the medical tech company lifted the lower end of its annual profit forecast for a second time, banking on sustained demand for its medical devices in the US.

  • Trump Media & Technology Group (NASDAQ:DJT) stock fell 4.9%, handing back some of the previous session’s 16% gains following a report that the social media company was in talks to buy crypto trading platform Bakkt.

  • Berry Global (NYSE:BERY) stock rose 4.4% after the packing company agreed to be acquired by Amcor (NYSE:AMCR), down 1.1%, for about $8.4 billion in a sign that the merger landscape is starting to heat up.

  • BioNTech (NASDAQ:BNTX) stock rose 1.9% after Evercore ISI upgraded its stance on the drugmaker to ‘outperform’ from ‘in line’, citing a combination of opportunism, a cheap valuation, and an increasingly compelling fundamental outlook around its “deep and staggered” oncology pipeline.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.